GLP-1 Therapies Enter the CKM Guideline For the first time, GLP-1-based therapy is recommended to reduce cardiac events. Diabzen, [S. l.], v. 4, n. 18, p. 36–37, 2026. Disponível em: https://thediabzen.com/index.php/d/article/view/61. Acesso em: 28 jul. 2026.